|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.26 BRL | -0.74% |
|
-2.01% | -37.48% |
| May. 08 | Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 07 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Blau Farmacêutica S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was BRL 1,366.41 million compared to BRL 1,181.8 million a year ago. Net income was BRL 325.22 million compared to BRL 254.33 million a year ago.
Basic earnings per share from continuing operations was BRL 1.8917 compared to BRL 1.7184 a year ago. Diluted earnings per share from continuing operations was BRL 1.8917 compared to BRL 1.6139 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -37.48% | 348M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
BLAU FARMACÊUTICA S.A. 
